myLaurel® | $12,000,000 | (Jun 4, 2025)
Matterworks | Undisclosed Amount | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Certified by Founder
Lodge
Seismic Therapeutic
start up
United States
- Cambridge, MA
- 05/12/2023
- Series B
- $121,000,000
We are The Machine Learning Immunology Company. Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics drug discovery and development process. Using our IMPACT™ platform, we are fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies for patients. Seismic Therapeutic has an emerging pipeline of novel approaches to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.
- Industry Biotechnology Research
- Website http://www.seismictx.com/
- LinkedIn https://www.linkedin.com/company/seismic-therapeutic/about/
FISPAN | $30,000,000 | (Jun 4, 2025)
Volare Solutions | $29,578,562 | (Jun 4, 2025)
Skyral | $20,000,000 | (Jun 4, 2025)
Compyl | $12,000,000 | (Jun 4, 2025)
Veris AI | $8,500,000 | (Jun 4, 2025)
Clara(US) | $3,100,000 | (Jun 4, 2025)
Akadeum Life Sciences, Inc. | $20,000,000 | (Jun 4, 2025)
ProteinQure | $11,000,000 | (Jun 4, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)